0001209191-21-049120.txt : 20210802
0001209191-21-049120.hdr.sgml : 20210802
20210802184911
ACCESSION NUMBER: 0001209191-21-049120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210729
FILED AS OF DATE: 20210802
DATE AS OF CHANGE: 20210802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Siegel Jolie
CENTRAL INDEX KEY: 0001768223
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39567
FILM NUMBER: 211137320
MAIL ADDRESS:
STREET 1: C/O NEON THERAPEUTICS, INC.
STREET 2: 40 ERIE ST., SUITE 110
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: C4 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662579
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475617627
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (617) 231-0700
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-29
0
0001662579
C4 Therapeutics, Inc.
CCCC
0001768223
Siegel Jolie
C/O C4 THERAPEUTICS, INC.
490 ARSENAL WAY #200
WATERTOWN
MA
02472
0
1
0
0
Chief Legal Officer
Common Stock
2021-07-29
4
M
0
12500
4.98
A
12500
D
Common Stock
2021-07-29
4
S
0
12500
45.00
D
0
D
Stock Option (Right to Buy)
4.98
2021-07-29
4
M
0
12500
0.00
D
2030-07-02
Common Stock
12500
283821
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
20% of this option vested and became exercisable on July 1, 2021, with the remainder vesting in 16 equal quarterly installments thereafter.
/s/ Shoaib Ghias, Attorney-in-Fact
2021-08-02